—Kerry Fowler, principal, KFW Consulting
—Paul Fredlund, biotechnology consultant
—Steven Frey, Theraclone Sciences
—Mark Fromhold, vice president of manufacturing and process development, Koronis Pharmaceuticals
—Lyn Frumkin, biotechnology consultant
—Michael Gallatin, president, Calistoga Pharmaceuticals
—Christopher Gann, vice president, Starbucks
—Bob Garcia Jr., senior research associate scientist, Genentech
—Leon Garcia-Martinez, associate director, Alder Biopharmaceuticals
—Jeff Gardin, IT director, CMC Icos
—Dean Gittleman, senior director of biometrics, Vertex Pharmaceuticals [Added 12/30/09]
—Phyllis Goldman, senior program manager, Merck
—David Goodkin, independent biotechnology professional
—Kathy Goodman, executive assistant
—Rebecca Gottschalk, senior research associate, Trubion Pharmaceuticals
—Patrick Gray, chief scientific director, Accelerator
—Melanie Gray, medical student
—Jacinthe Guindon, director of clinical operations, Viventia Biotech
—Stephen Hadley, vice president of quality, CMC Icos
—Jim Halbrook, senior research scientist, Albany Molecular Research
—Kristi Hamilton, research associate III, Institute for Systems Biology
—Christine Hansen, senior research associate, Seattle Genetics
—Lori Hansen, director of project management, Seattle Genetics
—Kevin Harbol, senior group leader, Omeros
—Pat Hardwick, information technology support manager, College Success Foundation
—Justin Hare, in vivo toxicology study coordinator, Amgen
—Edith Harris, scientist, Mirina
—Nataly Hawthorn, biotechnology professional
—Joel Hayflick, former senior oncology early product development team leader, Genentech
—Allen Heck, director of operations, Northshore Sheet Metal
—Lee Hendrickson, owner, Side Street Photographics
—Christopher Henney, chairman of the board, Oncothyreon, director, AVI Biopharma
—Kelly Hensley, senior associate scientist, Amgen
